Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research.

IF 3.7 2区 医学 Q1 RHEUMATOLOGY Lupus Science & Medicine Pub Date : 2024-10-14 DOI:10.1136/lupus-2024-001329
Candace Feldman, Jeffrey R Curtis, Jim C Oates, Jinoos Yazdany, Peter Izmirly
{"title":"Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research.","authors":"Candace Feldman, Jeffrey R Curtis, Jim C Oates, Jinoos Yazdany, Peter Izmirly","doi":"10.1136/lupus-2024-001329","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to validate claims-based algorithms for identifying SLE and lupus nephritis (LN) in Medicare data, enhancing the use of the Lupus Index for geospatial research on SLE prevalence and outcomes.</p><p><strong>Methods: </strong>We retrospectively evaluated the performance of rule-based algorithms using the International Classification of Diseases, 10th Revision (ICD-10) codes to identify SLE and LN in a well-defined prospective longitudinal cohort of patients with and without SLE from a South Carolina registry and rheumatology outpatient clinics. The analysis included comparison of algorithms based on Medicare fee-for-service claims data to these rigorously phenotyped populations. The primary classification for SLE cases was based on the American College of Rheumatology and Systemic Lupus Erythematosus International Collaborating Clinics criteria for SLE and LN. Algorithms were based on the number of ICD-10 codes with and without a 30-day separation in the observation period, including all of 2016-2018.</p><p><strong>Results: </strong>The algorithm using two ICD-10 codes for SLE, with or without a 30-day separation, showed the best overall performance. For LN, specific ICD-10 codes outperformed combinations of SLE and renal/proteinuria codes that were found in ICD-9.</p><p><strong>Conclusions: </strong>The findings of this study highlight the performance of specific ICD-10 code algorithms in identifying SLE and LN cases within Medicare data, providing a valuable tool for informing use of the Lupus Index. This index allows for improved geographical targeting of clinical resources, health disparity studies and clinical trial site selection. The study underscores the importance of algorithm selection based on research objectives, recommending more specific algorithms for precise tasks like clinical trial site identification and less specific ones for broader applications such as health disparities research.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"11 2","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11474710/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2024-001329","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to validate claims-based algorithms for identifying SLE and lupus nephritis (LN) in Medicare data, enhancing the use of the Lupus Index for geospatial research on SLE prevalence and outcomes.

Methods: We retrospectively evaluated the performance of rule-based algorithms using the International Classification of Diseases, 10th Revision (ICD-10) codes to identify SLE and LN in a well-defined prospective longitudinal cohort of patients with and without SLE from a South Carolina registry and rheumatology outpatient clinics. The analysis included comparison of algorithms based on Medicare fee-for-service claims data to these rigorously phenotyped populations. The primary classification for SLE cases was based on the American College of Rheumatology and Systemic Lupus Erythematosus International Collaborating Clinics criteria for SLE and LN. Algorithms were based on the number of ICD-10 codes with and without a 30-day separation in the observation period, including all of 2016-2018.

Results: The algorithm using two ICD-10 codes for SLE, with or without a 30-day separation, showed the best overall performance. For LN, specific ICD-10 codes outperformed combinations of SLE and renal/proteinuria codes that were found in ICD-9.

Conclusions: The findings of this study highlight the performance of specific ICD-10 code algorithms in identifying SLE and LN cases within Medicare data, providing a valuable tool for informing use of the Lupus Index. This index allows for improved geographical targeting of clinical resources, health disparity studies and clinical trial site selection. The study underscores the importance of algorithm selection based on research objectives, recommending more specific algorithms for precise tasks like clinical trial site identification and less specific ones for broader applications such as health disparities research.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
验证医疗保险数据中系统性红斑狼疮诊断的索赔算法,以便在知情的情况下使用狼疮指数:地理空间研究工具。
目的:本研究旨在验证在医疗保险(Medicare)数据中识别系统性红斑狼疮和狼疮性肾炎(LN)的索赔算法,从而加强狼疮指数在系统性红斑狼疮患病率和预后地理空间研究中的应用:我们回顾性地评估了基于规则的算法的性能,这些算法使用《国际疾病分类》第 10 次修订版(ICD-10)代码,在一个定义明确的前瞻性纵向队列中识别系统性红斑狼疮和狼疮肾炎,该队列包括来自南卡罗来纳州登记处和风湿病门诊的系统性红斑狼疮患者和非系统性红斑狼疮患者。分析包括将基于医疗保险付费服务索赔数据的算法与这些严格表型的人群进行比较。系统性红斑狼疮病例的主要分类基于美国风湿病学会和系统性红斑狼疮国际合作诊所的系统性红斑狼疮和LN标准。算法基于观察期内(包括 2016-2018 年的所有时间)有 30 天间隔和无 30 天间隔的 ICD-10 编码数量:对系统性红斑狼疮使用两个 ICD-10 编码(无论是否有 30 天的间隔)的算法显示出最佳的整体性能。对于 LN,特定的 ICD-10 编码优于 ICD-9 中的系统性红斑狼疮和肾脏/蛋白尿编码组合:结论:本研究结果强调了特定 ICD-10 编码算法在医疗保险数据中识别系统性红斑狼疮和 LN 病例的性能,为狼疮指数的使用提供了宝贵的参考工具。该指数可改善临床资源的地理定位、健康差异研究和临床试验地点的选择。这项研究强调了根据研究目标选择算法的重要性,建议使用更具体的算法来完成临床试验地点识别等精确任务,而使用不那么具体的算法来完成健康差异研究等更广泛的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
期刊最新文献
Altered structural and functional homotopic connectivity associated with cognitive changes in SLE. Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol. Development of a predictive model for systemic lupus erythematosus incidence risk based on environmental exposure factors. Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review and meta-analysis. Role of intravenous immunoglobulins in the management of systemic lupus erythematosus: a single-centre experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1